|
|
Volumn 21, Issue 14, 2013, Pages 4158-4169
|
|
Synthesis and bioactive evaluation of novel hybrids of metronidazole and berberine as new type of antimicrobial agents and their transportation behavior by human serum albumin
|
|
Author keywords
Antibacterial; Antifungal; Berberine; Human serum albumin; Imidazole; Metronidazole
|
|
Indexed keywords
2 BROMO N (2 CHLOROBENZYL) N [2 (4 NITRO 1H IMIDAZOL 1 YL)ETHYL]ETHANAMINE;
2 BROMO N (2 CHLOROBENZYL) N [2 (5 NITRO 1H IMIDAZOL 1 YL)ETHYL]ETHANAMINE;
2 BROMO N (2,4 DIFLUOROBENZYL) N [2 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)ETHYL]ETHANAMINE;
2 BROMO N (2,4 DIFLUOROBENZYL) N [2 (4 NITRO 1H IMIDAZOL 1 YL)ETHYL]ETHANAMINE;
2 BROMO N (2,4 DIFLUOROBENZYL) N [2 (5 NITRO 1H IMIDAZOL 1 YL)ETHYL]ETHANAMINE;
2 BROMO N (3 CHLOROBENZYL) N [2 (4 NITRO 1H IMIDAZOL 1 YL)ETHYL]ETHANAMINE;
2 BROMO N (3 CHLOROBENZYL) N [2 (5 NITRO 1H IMIDAZOL 1 YL)ETHYL]ETHANAMINE;
2 BROMO N (3,4 DICHLOROBENZYL) N [2 (4 NITRO 1H IMIDAZOL 1 YL)ETHYL]ETHANAMINE;
2 BROMO N (3,4 DICHLOROBENZYL) N [2 (5 NITRO 1H IMIDAZOL 1 YL)ETHYL]ETHANAMINE;
2 BROMO N (4 CHLOROBENZYL) N [2 (4 NITRO 1H IMIDAZOL 1 YL)ETHYL]ETHANAMINE;
2 BROMO N (4 CHLOROBENZYL) N [2 (5 NITRO 1H IMIDAZOL 1 YL)ETHYL]ETHANAMINE;
ANTIFUNGAL AGENT;
ANTIINFECTIVE AGENT;
BERBERINE;
FLUCONAZOLE;
HUMAN SERUM ALBUMIN;
METRONIDAZOLE;
N (2 CHLOROBENZYL) N (2 (4 NITRO 1H IMIDAZOL 1 YL)ETHYL) 2 (2 BERBERINOXYETHOXY)ETHANAMINE;
N (2 CHLOROBENZYL) N (2 (5 NITRO 1H IMIDAZOL 1 YL)ETHYL) 2 (2 BERBERINOXYETHOXY)ETHANAMINE;
N (2,4 DIFLUOROBENZYL) N (2 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)ETHYL) 2 (2 BERBERINOXYETHOXY)ETHANAMINE;
N (2,4 DIFLUOROBENZYL) N (2 (4 NITRO 1H IMIDAZOL 1 YL)ETHYL) 2 (2 BERBERINOXYETHOXY)ETHANAMINE;
N (2,4 DIFLUOROBENZYL) N (2 (5 NITRO 1H IMIDAZOL 1 YL)ETHYL) 2 (2 BERBERINOXYETHOXY)ETHANAMINE;
N (3 CHLOROBENZYL) N (2 (4 NITRO 1H IMIDAZOL 1 YL)ETHYL) 2 (2 BERBERINOXYETHOXY)ETHANAMINE;
N (3 CHLOROBENZYL) N (2 (5 NITRO 1H IMIDAZOL 1 YL)ETHYL) 2 (2 BERBERINOXYETHOXY)ETHANAMINE;
N (3,4 DICHLOROBENZYL) N (2 (4 NITRO 1H IMIDAZOL 1 YL)ETHYL) 2 (2 BERBERINOXYETHOXY)ETHANAMINE;
N (3,4 DICHLOROBENZYL) N (2 (5 NITRO 1H IMIDAZOL 1 YL)ETHYL) 2 (2 BERBERINOXYETHOXY)ETHANAMINE;
N (4 CHLOROBENZYL) N (2 (4 NITRO 1H IMIDAZOL 1 YL)ETHYL) 2 (2 BERBERINOXYETHOXY)ETHANAMINE;
N (4 CHLOROBENZYL) N (2 (5 NITRO 1H IMIDAZOL 1 YL)ETHYL) 2 (2 BERBERINOXYETHOXY)ETHANAMINE;
NORFLOXACIN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ABSORPTION SPECTROSCOPY;
ANTIBACTERIAL ACTIVITY;
ANTIFUNGAL ACTIVITY;
ARTICLE;
BINDING AFFINITY;
BINDING SITE;
CARBON NUCLEAR MAGNETIC RESONANCE;
CONCENTRATION (PARAMETERS);
CONTROLLED STUDY;
DRUG DETERMINATION;
DRUG SCREENING;
DRUG SOLUBILITY;
DRUG STABILITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
DRUG TRANSPORT;
FLUORESCENCE ANALYSIS;
INFRARED SPECTROSCOPY;
MASS SPECTROMETRY;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MOLECULAR MODEL;
NONHUMAN;
PROTON NUCLEAR MAGNETIC RESONANCE;
REACTION ANALYSIS;
STATIC ELECTRICITY;
STRUCTURE ANALYSIS;
TEMPERATURE MEASUREMENT;
THERMODYNAMICS;
ANTI-INFECTIVE AGENTS;
BACTERIA;
BERBERINE;
BINDING SITES;
BIOLOGICAL TRANSPORT;
FUNGI;
HUMANS;
MAGNETIC RESONANCE SPECTROSCOPY;
METRONIDAZOLE;
MOLECULAR STRUCTURE;
SERUM ALBUMIN;
THERMODYNAMICS;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
|
|
EID: 84879030355
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2013.05.007 Document Type: Article |
|
Times cited : (66)
|
|
References (44)
|
